Department of Urology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Department of Urology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
In Vivo. 2022 Nov-Dec;36(6):2800-2805. doi: 10.21873/invivo.13017.
BACKGROUND/AIM: This study aimed to determine whether psychological stress associated with the COVID-19 pandemic might exacerbate lower urinary tract symptoms (LUTS) and decrease lower urinary tract function in outpatients with LUTS.
We evaluated 104 patients who visited our hospital during the first wave of the COVID-19 pandemic. Psychological stress was evaluated by the Stress Response Scale-18 (SRS-18). Subjects were divided into aggravation and non-aggravation of psychological stress groups according to the SRS-18. LUTS was evaluated according to the International Prostate Symptom Score (IPSS). Lower urinary tract function was evaluated as the post-void residual urine volume (PVR). Comparisons of scores and changes in scores of each parameter before versus during/after the first wave of the COVID-19 pandemic were performed between the two groups.
Forty-two patients were included in each group. We observed no significant differences in the comparison of scores at each time point and in changes in total IPSS score, voiding symptom subscores and PVR between the two groups. Although no significant differences in storage symptom subscores were observed between the two groups, changes in storage symptom subscores increased significantly during the first wave of the pandemic in the aggravation of psychological stress group (p=0.02). However, no significant increase was observed after the first wave.
Psychological stress during the COVID-19 pandemic might transiently aggravate storage symptoms in patients with LUTS. Physicians should be aware of the possibility of transient worsening of LUTS during future pandemics, and transiently additional medication might be effective in such patients.
背景/目的:本研究旨在确定 COVID-19 大流行相关的心理压力是否会加重门诊患者的下尿路症状(LUTS)并降低下尿路功能。
我们评估了 104 名在 COVID-19 大流行第一波期间就诊于我院的患者。通过应激反应量表-18(SRS-18)评估心理压力。根据 SRS-18 将受试者分为心理压力加重和不加重组。根据国际前列腺症状评分(IPSS)评估 LUTS。通过剩余尿量(PVR)评估下尿路功能。比较两组之间每个参数在大流行第一波前后的评分和评分变化。
每组纳入 42 例患者。两组之间在各时间点的评分比较和总 IPSS 评分、排尿症状子评分和 PVR 的评分变化均无显著差异。虽然两组之间的存储症状子评分无显著差异,但在心理压力加重组,在大流行第一波期间存储症状子评分的变化显著增加(p=0.02)。但是,在第一波之后没有观察到显著增加。
COVID-19 大流行期间的心理压力可能会使 LUTS 患者的储存症状短暂加重。医生应注意在下一次大流行期间 LUTS 可能会短暂恶化的可能性,对于此类患者,暂时增加药物治疗可能是有效的。